Microsoft's quantum leap with Majorana 1 and Azure integration makes it the stronger buy over IonQ's high-risk, ...

The gout market is poised for steady growth, driven by the rising prevalence of the disease, increasing awareness, and the launch of novel therapies such as AR-882, Epaminurad, XNW3009, XRx-026, ...